Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Avalon Globocare Has Received A Notice Of Allowance For Its U.S. Patent Application 17/210,837 Titled “Qty Fc Fusion Water Soluble Receptor Proteins (For The Treatment Of Cytokine Release Syndrome)”

https://twitter.com/PatentGrants/status/1569347853348388864   https://patentcenter.uspto.gov/applications/17210837/ifw/docs
byBenzinga Newsdesk
September 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

https://patentcenter.uspto.gov/applications/17210837/ifw/docs

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts